Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.06.20.660675

Dynamic cholinergic signaling differentially desynchronizes cortical microcircuits dependent on modulation rate and network topology

Abstract

Acetylcholine (ACh) affects both the intrinsic properties of individual neurons and the oscillatory tendencies of neuronal microcircuits by modulating the muscarinic-receptor gated m-current. However, despite contemporary experimental evidence of ACh concentrations changing at millisecond timescales, computational studies traditionally model ACh solely as a tonic neuromodulator. How time-varying, dynamic cholinergic modulation of the m-current affects the dynamics of neuronal microcircuits therefore remains an open question. Using a new implementation of a time-varying cholinergic signal in computational excitatory-inhibitory (E-I) spiking neuronal networks, we here delineate how the interaction between dynamic cholinergic modulation and network topology influences the oscillatory tendencies of these systems. While the dynamics of networks with dominant inter-connectivity (strong E-to-I and I-to-E synaptic weights) are minimally affected, networks with dominant intra-connectivity (strong E-to-E and I-to-I synaptic weights) exhibit dynamics heavily dependent upon dynamic cholinergic signaling. Further investigation of these latter type of networks reveals that their firing patterns are sensitive to the timecourse of cholinergic modulation and that relatively minor changes to the E-I connectivity strength promote distinct desynchronization mechanisms. Our results indicate that network topology plays a paramount role in dictating the modulatory effects of time-varying cholinergic signals, a finding of broad relevance to our understanding of cholinergic modulation and potentially impactful in the design of neurostimulation therapies believed to act through cholinergic pathways. Author summaryAcetylcholine (ACh) is a chemical messenger that alters the intrinsic properties of neurons and in turn regulates brain activity related to cognitive functions such as sensory processing, memory formation, and attention. Although mounting experimental evidence shows that ACh concentrations in the brain can change dynamically at rapid timescales, computational studies conventionally consider ACh concentrations as constant across time. This motivated us to create a computational model of a neuronal microcircuit in which cellular properties are affected by ACh concentrations varying at millisecond-level timescales. The oscillatory dynamics of this microcircuit differ in important ways from similar systems with constant ACh levels, with the influence of dynamically changing ACh critically dependent upon the connectivity of the neurons in the modeled brain region. These results describe novel mechanisms by which ACh controls microcircuit activity overlooked in existing models in which ACh varies only over long timescales, an understanding which may be vital for the refinement of neurostimulation therapies believed to act through transient alterations to ACh activity.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Pandian, S., Rich, S.. 2025-06-22. Dynamic cholinergic signaling differentially desynchronizes cortical microcircuits dependent on modulation rate and network topology. https://doi.org/10.1101/2025.06.20.660675

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗